• Search
  • Helpdesk
  • Sales contact
Get your demo

Working with patient associations: What is the key to a positive interaction?

Patients insightsRare disease
Last updated: April 13, 2026

What rare disease patients and families want is a simpler life. 
Discover here what makes the relationship between the members of the patients’ association and a company work so well.

Check our Youtube channel for more videos!
Follow us on social media
Subscribe to our newsletter
You may also like

Better Raters,Smarter eCOA,Stronger Data

Strengthening Endpoint Reliability: An Interview with Estelle Haenel, Chief Medical...

Kayentis and RWS join forces to improve data confidence in...

What if eCOA could elevate your next rare disease trial?

Elevating rare disease clinical trials through eCOA – From patient...

Overcoming rare disease trial challenges: the strategic impact of eCOA

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.
Meet us at the following events

6th Annual Clinical Trial Innovation Summit

24 JUNE 2026 • BASEL, CH

DPHARM 2026

SEPT 15-16 2026 • Boston, MA, USA
Booth #306